ENAapplication/xmlftp.sra.ebi.ac.uk/vol1/fastq/SRR113/003/SRR1137473/SRR1137473.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR113/009/SRR1137469/SRR1137469.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR113/002/SRR1137462/SRR1137462.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR113/000/SRR1137460/SRR1137460.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR113/004/SRR1137454/SRR1137454.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR113/008/SRR1137458/SRR1137458.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR113/005/SRR1137465/SRR1137465.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR113/006/SRR1137466/SRR1137466.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR113/003/SRR1137463/SRR1137463.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR113/001/SRR1137471/SRR1137471.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR113/008/SRR1137468/SRR1137468.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR113/004/SRR1137474/SRR1137474.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR113/007/SRR1137457/SRR1137457.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR113/005/SRR1137455/SRR1137455.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR113/006/SRR1137476/SRR1137476.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR113/009/SRR1137459/SRR1137459.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR113/002/SRR1137472/SRR1137472.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR113/001/SRR1137461/SRR1137461.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR113/004/SRR1137464/SRR1137464.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR113/003/SRR1137453/SRR1137453.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR113/007/SRR1137467/SRR1137467.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR113/005/SRR1137475/SRR1137475.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR113/000/SRR1137470/SRR1137470.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR113/006/SRR1137456/SRR1137456.fastq.gzprimaryOK2000000GenomicsMultiomicsCentre for Immunity, Infection and Evolutionhttps://www.ebi.ac.uk/ena/browser/view/PRJNA236014Homo sapiensVaccinia virus (VACV) is a large cytoplasmic dsDNA virus that causes dramatic alterations to many cellular pathways including microRNA biogenesis. Here we use small RNA sequencing to comprehensively quantify the impact of VACV infection on the expression of endogenous small non-coding RNAs (sncRNAs) at both early (6 h) and late (24 h) times post infection. Overall design: Non-coding RNAs (sncRNAs) were assessed at 6 hours and 24 hours, in naive and VACV-infected HeLa cells, in the presence or absence of the inhibitor AraC. There were three replicates for each of the eight groups.ENApri miRNA, infection, viral infection, RNA, miRNAs, Small Temporal, human being, Viruses, Micro, Temporal RNA, Polyadenylations, stRNA, Small Temporal RNA, Primary MicroRNA, Primary, infections, miRNA, Primary miRNA, Viruses infection, man, pri-miRNA, Viruses disease or disorder., human, Small, Micro RNA, Viruses caused disease or disorder, viral infectious disease, viral disorder, virus infection, Viruses infectious disease, MicroRNA, viral disease, pre-miRNA, viral, pre miRNAhuman being, human., man0.00.00.00.00.00falseHomo sapiensDiversity in the polyadenylation and decay of human cellular microRNAs during Vaccinia virus infection2022-05-122015-07-17PRJNA236014GSE54235261615609606